Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/12/19 | 8-K | Current report filing |
|
4 | |
| 11/12/19 | D/A | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 11/07/19 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
58 | |
| 11/07/19 | 8-K | Current report filing |
|
16 | |
| 10/31/19 | 8-K | Current report filing |
|
4 | |
| 10/22/19 | 8-K | Current report filing |
|
39 | |
| 10/10/19 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/10/19 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/10/19 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/08/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
